Ultrasound-guided Modified Transversus Thoracic Muscle Plane Block and Erector Spinal Muscle Plane Block in Heart Valve Replacement Surgery With Median Incision
1 other identifier
interventional
60
1 country
1
Brief Summary
Sternum midline incision can offer better view under open-heart surgery and bigger operating space, and therefore it has been widely used in most cardiac surgery. If an event of urgency occurs, it takes on a more important role than infrasternal small incision. However, sternum midline incision may cause serious pain and aggravates stress response, and therefore patients are often reluctant to cooperate to cough which exerts adverse effect on postoperative rehabilitation, and even causes serious complications such as pulmonary inflammation, myocardial infarction and heart failure. Thus, the relief of pain and better perioperative analgesia are very important for these patients. Transversus thoracic muscle plane(TTMP) block and erector spinal muscle plane(ESP) block are used in open heart surgery currently, and they can provide good analgesia. This study aimed to investigate the hemodynamic stability, total amount of analgesic use, perioperative pain, stress response, postoperative complication and recovery in patients receiving TMP and ESP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 16, 2024
CompletedFirst Posted
Study publicly available on registry
June 21, 2024
CompletedStudy Start
First participant enrolled
June 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedJune 21, 2024
June 1, 2024
2 months
June 16, 2024
June 16, 2024
Conditions
Outcome Measures
Primary Outcomes (14)
Mean arterial pressure
an average blood pressure in an individual during a single cardiac cycle
entering the operating room (T0)
Mean arterial pressure
an average blood pressure in an individual during a single cardiac cycle
intubation (T1)
Mean arterial pressure
an average blood pressure in an individual during a single cardiac cycle
skin incision (T2)
Mean arterial pressure
an average blood pressure in an individual during a single cardiac cycle
breast opening (T3)
Mean arterial pressure
an average blood pressure in an individual during a single cardiac cycle
sternal retractor placement (T4)
Mean arterial pressure
an average blood pressure in an individual during a single cardiac cycle
pericardium incision (T5)
Mean arterial pressure
an average blood pressure in an individual during a single cardiac cycle
steel wire pulling (T6)
Heart beats
the number of times each minute that heart beats
entering the operating room (T0)
Heart beats
the number of times each minute that heart beats
intubation (T1)
Heart beats
the number of times each minute that heart beats
skin incision (T2)
Heart beats
the number of times each minute that heart beats
breast opening (T3)
Heart beats
the number of times each minute that heart beats
sternal retractor placement (T4)
Heart beats
the number of times each minute that heart beats
pericardium incision (T5)
Heart beats
the number of times each minute that heart beats
steel wire pulling (T6)
Study Arms (3)
Transversus thoracic muscle plane block (T) group
EXPERIMENTALErector spinal plane block (E) group
EXPERIMENTALGeneral anesthesia only (G) group
NO INTERVENTIONInterventions
Transversus thoracic muscle plane block or Erector spinal plane block
Eligibility Criteria
You may qualify if:
- patients (18-75 years) with BMI at 18-25 kg/m2, ASA Ⅱ- Ⅲ and NYHA Ⅱ-Ⅲ who scheduled to undergo mitral valve or aortic valve replacement surgery.
You may not qualify if:
- a second operation, preoperative ejection fraction (EF) \< 40%, complicated coronary heart disease, intra-aortic balloon counterpulsation (IABP) support, psychiatric abnormalities, history of allergy to anesthetic drugs, liver or kidney dysfunction, coagulation abnormality, endocrine system diseases and metabolic diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Le Yulead
Study Sites (1)
Shanghai East Hospital of Tongji University
Shanghai, Shanghai Municipality, 200120, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinicians
Study Record Dates
First Submitted
June 16, 2024
First Posted
June 21, 2024
Study Start
June 25, 2024
Primary Completion
August 25, 2024
Study Completion
September 1, 2024
Last Updated
June 21, 2024
Record last verified: 2024-06